Spontaneous adverse event reports pose significant challenges to pharmacovigilance scientists. How may we turn them into opportunities that benefit our pharmacovigilance systems?

04 June 2025

To tackle the lack of medicine and vaccine safety data for pregnant people, UMC has developed an algorithm to more easily identify pregnancy-related reports in VigiBase.

21 January 2025

AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

22 October 2024

The READUS-PV statement is the first-ever guide for reports of disproportionality analyses that are replicable, reliable, and reproducible.

07 October 2024